Effects of High-Dose Vitamin D Supplementation on Placental Vitamin D Metabolism and Neonatal Vitamin D Status
Nutrients · 05.07.2024 · 16 (13) · 2145
DOI: 10.3390/nu16132145 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, online erschienen am 05.07.2024. Verfasst von Anna Louise Vestergaard und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, Randers Regional Hospital, 8930 Randers, Denmark. Hauptthemen laut MEDLINE: Placenta, Vitamin D, Dietary Supplements, Vitamin D Deficiency. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Aarhus University, Aase og Ejnar Danielsens Fond, Axel Muusfeldts Fond.
Abstract (Originalsprache)
Vitamin D (vitD) deficiency (25-hydroxy-vitamin D < 50 nmol/L) is common in pregnancy and associated with an increased risk of adverse pregnancy outcomes. High-dose vitD supplementation is suggested to improve pregnancy health, but there is limited knowledge about the effects on placental vitD transport and metabolism and the vitD status of newborns. Comparing the current standard maternal supplementation, 10 µg/day to a 90 µg vitD supplement, we investigated placental gene expression, maternal vitD transport and neonatal vitD status. Biological material was obtained from pregnant women randomized to 10 µg or 90 µg vitD supplements from week 11–16 onwards. Possible associations between maternal exposure, neonatal vitD status and placental expression of the vitD receptor (VDR), the transporters (Cubilin, CUBN and Megalin, LRP2) and the vitD-activating and -degrading enzymes (CYP24A1, CYP27B1) were investigated. Maternal vitD-binding protein (VDBP) was determined before and after supplementation. Overall, 51% of neonates in the 10 µg vitD group were vitD-deficient in contrast to 11% in the 90 µg group. High-dose vitD supplementation did not significantly affect VDBP or placental gene expression. However, the descriptive analyses indicate that maternal obesity may lead to the differential expression of CUBN, CYP24A1 and CYP27B1 and a changed VDBP response. High-dose vitD improves neonatal vitD status without affecting placental vitD regulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynaecology, Randers Regional Hospital, 8930 Randers, Denmark.
- Department of Clinical Medicine, Aarhus University, 8200 Aarhus, Denmark.
- Department of Biomedicine, Aarhus University, 8000 Aarhus, Denmark.
- Department of Obstetrics and Gynaecology, Aarhus University Hospital, 8200 Aarhus, Denmark.
ORCID-Profile: Anna Louise Vestergaard, Matilde Kanstrup Andersen, Helena Hørdum Andersen, Krista Agathe Bossow
Förderung
- Aarhus University
- Aase og Ejnar Danielsens Fond
- Axel Muusfeldts Fond
- Augustinus Foundation
- Danish Medical Association
- The Toyota Foundation
- Director Emil C.Hertz and Wife Inger Hertz' Foundation
- Dagmar Marshalls Fond
Zitieren
APA
Vestergaard, A. L., Andersen, M. K., Andersen, H. H., Bossow, K. A., Bor, P., & Larsen, A. (2024). Effects of High-Dose Vitamin D Supplementation on Placental Vitamin D Metabolism and Neonatal Vitamin D Status. Nutrients, 16(13), 2145. https://doi.org/10.3390/nu16132145
Vancouver
Vestergaard AL, Andersen MK, Andersen HH, Bossow KA, Bor P, Larsen A. Effects of High-Dose Vitamin D Supplementation on Placental Vitamin D Metabolism and Neonatal Vitamin D Status. Nutrients. 2024;16(13):2145. doi:10.3390/nu16132145
BibTeX
@article{Vestergaard2024,
author = {Vestergaard, Anna Louise and Andersen, Matilde Kanstrup and Andersen, Helena Hørdum and Bossow, Krista Agathe and Bor, Pinar and Larsen, Agnete},
title = {Effects of High-Dose Vitamin D Supplementation on Placental Vitamin D Metabolism and Neonatal Vitamin D Status},
journal = {Nutrients},
year = {2024},
volume = {16},
number = {13},
pages = {2145},
doi = {10.3390/nu16132145}
}
EUVIMED